155 related articles for article (PubMed ID: 18342228)
41. Effects of Canagliflozin on Amino-Terminal Pro-B-Type Natriuretic Peptide: Implications for Cardiovascular Risk Reduction.
Januzzi JL; Xu J; Li J; Shaw W; Oh R; Pfeifer M; Butler J; Sattar N; Mahaffey KW; Neal B; Hansen MK
J Am Coll Cardiol; 2020 Nov; 76(18):2076-2085. PubMed ID: 33121714
[TBL] [Abstract][Full Text] [Related]
42. Association of N-terminal pro-brain natriuretic peptide with survival among US cancer survivors.
Cao C; Yang L; Nohria A; Mayer EL; Partridge AH; Ligibel JA
J Natl Cancer Inst; 2024 Jun; 116(6):938-947. PubMed ID: 38299668
[TBL] [Abstract][Full Text] [Related]
43. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease.
Zhang B; Xu H; Zhang H; Liu Q; Ye Y; Hao J; Zhao Q; Qi X; Liu S; Zhang E; Xu Y; Gao R; Pibarot P; Clavel MA; Wu Y;
J Am Coll Cardiol; 2020 Apr; 75(14):1659-1672. PubMed ID: 32273031
[TBL] [Abstract][Full Text] [Related]
44. Prospective Validation of a Screening Biomarker Approach Combining Amino-Terminal Pro-Brain Natriuretic Peptide With Galectin-3 Predicts Death and Cardiovascular Events in Asymptomatic Hemodialysis Patients.
Voroneanu L; Siriopol D; Apetrii M; Hogas S; Onofriescu M; Nistor I; Kanbay M; Dumea R; Cusai S; Cianga P; Constantinescu D; Covic A
Angiology; 2018 May; 69(5):449-455. PubMed ID: 28974104
[TBL] [Abstract][Full Text] [Related]
45. Early discharge after primary percutaneous coronary intervention: the added value of N-terminal pro-brain natriuretic peptide to the Zwolle Risk Score.
Schellings DA; Adiyaman A; Giannitsis E; Hamm C; Suryapranata H; Ten Berg JM; Hoorntje JC; Van't Hof AW
J Am Heart Assoc; 2014 Nov; 3(6):e001089. PubMed ID: 25389283
[TBL] [Abstract][Full Text] [Related]
46. Prognostic value of plasma N-terminal pro B-type natriuretic peptide levels in pneumonia patients requiring intensive care unit admission.
Lin SC; Tsai YJ; Huang CT; Kuo YW; Ruan SY; Chuang YC; Yu CJ
Respirology; 2013 Aug; 18(6):933-41. PubMed ID: 23600467
[TBL] [Abstract][Full Text] [Related]
47. Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies.
Karthikeyan G; Moncur RA; Levine O; Heels-Ansdell D; Chan MT; Alonso-Coello P; Yusuf S; Sessler D; Villar JC; Berwanger O; McQueen M; Mathew A; Hill S; Gibson S; Berry C; Yeh HM; Devereaux PJ
J Am Coll Cardiol; 2009 Oct; 54(17):1599-606. PubMed ID: 19833258
[TBL] [Abstract][Full Text] [Related]
48. The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure.
Fu S; Xie L; Li D; Ye P; Luo L
Clin Interv Aging; 2015; 10():359-65. PubMed ID: 25670892
[TBL] [Abstract][Full Text] [Related]
49. N-terminal pro-brain natriuretic peptide and outcomes in patients undergoing surgical ventricular restoration.
Ballotta A; Ranucci M; Kunkl A; El Baghdady H; Bossone E; Castelvecchio S; Frigiola A; Menicanti L; Di Donato M; Mehta RH
Am J Cardiol; 2010 Mar; 105(5):640-4. PubMed ID: 20185010
[TBL] [Abstract][Full Text] [Related]
50. N-terminal pro-B-type natriuretic peptide concentrations and long-term outcome after cardiac surgery: a prospective cohort study.
Cuthbertson BH; Croal BL; Rae D; Harrild K; Gibson PH; Prescott GJ; Kengne AP; Hillis GS
Br J Anaesth; 2013 Feb; 110(2):214-21. PubMed ID: 23183321
[TBL] [Abstract][Full Text] [Related]
51. Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure.
Zile MR; Claggett BL; Prescott MF; McMurray JJ; Packer M; Rouleau JL; Swedberg K; Desai AS; Gong J; Shi VC; Solomon SD
J Am Coll Cardiol; 2016 Dec; 68(22):2425-2436. PubMed ID: 27908347
[TBL] [Abstract][Full Text] [Related]
52. Sex Differences in the Prognostic Power of Brain Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide for Cardiovascular Events - The Japan Morning Surge-Home Blood Pressure Study.
Taki M; Ishiyama Y; Mizuno H; Komori T; Kono K; Hoshide S; Kario K
Circ J; 2018 Jul; 82(8):2096-2102. PubMed ID: 29925742
[TBL] [Abstract][Full Text] [Related]
53. N-terminal pro-brain natriuretic peptide and adverse outcomes in Chinese patients with hypertrophic cardiomyopathy.
Zhang ZL; Xu YY; Qin Z; Lu YZ; Liu TD; Zhang L; Shangguan JH; Wang W; Tang JN; Zhang JY
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34940836
[TBL] [Abstract][Full Text] [Related]
54. Is elevation of N-terminal pro-B-type natriuretic peptide at discharge associated with 2-year composite endpoint of all-cause mortality and heart failure hospitalisation after transcatheter aortic valve implantation? Insights from a multicentre prospective OCEAN-TAVI registry in Japan.
Mizutani K; Hara M; Nakao M; Okai T; Kajio K; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
BMJ Open; 2018 Aug; 8(8):e021468. PubMed ID: 30121598
[TBL] [Abstract][Full Text] [Related]
55. Troponin I and NT-proBNP (N-terminal pro-brain natriuretic peptide) do not predict 6-month mortality in frail older patients undergoing orthopedic surgery.
Chong CP; van Gaal WJ; Ryan JE; Burrell LM; Savige J; Lim WK
J Am Med Dir Assoc; 2010 Jul; 11(6):415-20. PubMed ID: 20627182
[TBL] [Abstract][Full Text] [Related]
56. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
[TBL] [Abstract][Full Text] [Related]
57. Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study.
Ballo P; Betti I; Barchielli A; Balzi D; Castelli G; De Luca L; Gheorghiade M; Zuppiroli A
Clin Res Cardiol; 2016 May; 105(5):421-31. PubMed ID: 26547915
[TBL] [Abstract][Full Text] [Related]
58. The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis.
Rodseth RN; Biccard BM; Le Manach Y; Sessler DI; Lurati Buse GA; Thabane L; Schutt RC; Bolliger D; Cagini L; Cardinale D; Chong CP; Chu R; Cnotliwy M; Di Somma S; Fahrner R; Lim WK; Mahla E; Manikandan R; Puma F; Pyun WB; Radović M; Rajagopalan S; Suttie S; Vanniyasingam T; van Gaal WJ; Waliszek M; Devereaux PJ
J Am Coll Cardiol; 2014 Jan; 63(2):170-80. PubMed ID: 24076282
[TBL] [Abstract][Full Text] [Related]
59. N-terminal pro-brain natriuretic peptide identifies patients at high risk for adverse cardiac outcome after vascular surgery.
Mahla E; Baumann A; Rehak P; Watzinger N; Vicenzi MN; Maier R; Tiesenhausen K; Metzler H; Toller W
Anesthesiology; 2007 Jun; 106(6):1088-95. PubMed ID: 17525582
[TBL] [Abstract][Full Text] [Related]
60. Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery.
Feringa HH; Schouten O; Dunkelgrun M; Bax JJ; Boersma E; Elhendy A; de Jonge R; Karagiannis SE; Vidakovic R; Poldermans D
Heart; 2007 Feb; 93(2):226-31. PubMed ID: 16914484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
